Kenneth C Frazier
Director at Eikon Therapeutics, Inc. (EIKN)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-36.8%
vs. S&P 500-43.0%
Beat the market0%
Paper profit on buys−$1.2M
Total bought / sold$2.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 6SEC | EIKNEikon Therapeutics, Inc. | Buy | 111,111new position | $18.00 | $2.0M | -58.5% |
- Buy
Director Kenneth C Frazier bought $2.0M of EIKN at $18.00 — first open-market purchase in our records; opens a new position.